Denis Ochlast

Denis Ochlast started their work experience in 1995 as the Head of Controlling at Rolls-Royce Deutschland. Denis then moved on to Vodafone Germany, where they worked as the Head of Brand & MarComs Controlling from 2006 to 2014. In 2014, they took on the role of interim Leiter Controlling at Salutas Pharma GmbH, a NOVARTIS Company. From 2015 to 2016, they held interim positions as the interim Business Partner Controlling at Aeropharm GmbH and interim Kaufmännischer Leiter (CFO) at Sandoz industrial Products Frankfurt. In 2016, they became the interim Kaufmännischer Leiter (CFO) at Corden BioChem GmbH, where they were a member of the Geschäftsleitung and worked on integration, restructuring, and other special projects. Denis then moved on to ProConDo in 2014, where they worked in management consulting and interim management. Currently, since 2018, they are the VP of Finance US at AGC Biologics.

Denis Ochlast attended Fachschule für Wirtschaft Frankfurt am Main, where they pursued a degree in BWL (Betriebwirt S.a.). The duration of their education at this institution is not specified.